diaDexus

diaDexus is a privately held biotechnology company based in the United States, specializing in the discovery, development, and commercialization of innovative diagnostic products with significant clinical relevance. The company's flagship product, the PLAC Test, assesses levels of Lp-PLA2, an enzyme linked to the formation of harmful plaque in blood vessels, which is a key factor in cardiovascular events like heart disease and stroke. The PLAC Test is unique as it is the only FDA-cleared blood test that aids in evaluating the risk for coronary heart disease and ischemic stroke related to atherosclerosis. In addition to cardiovascular diagnostics, diaDexus offers test kits for various conditions, including liver disease, cancer markers, renal disease, diabetes, and electrolyte imbalances. The company primarily operates in the United States, with a growing presence in Europe and other regions worldwide.